|
|
| | 4H-Pyrido[1,2-a]pyrimidin-4-one, 7-(1-cyclopropyl-1H-pyrazol-4-yl)-2-[[2-fluoro-4-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]amino]-3-methyl- Basic information |
| | 4H-Pyrido[1,2-a]pyrimidin-4-one, 7-(1-cyclopropyl-1H-pyrazol-4-yl)-2-[[2-fluoro-4-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]amino]-3-methyl- Chemical Properties |
| Boiling point | 699.7±65.0 °C(Predicted) | | density | 1.51±0.1 g/cm3(Predicted) | | solubility | Acetonitrile: Slightly Soluble: 0.1-1 mg/ml DMSO: Sparingly Soluble: 1-10 mg/ml Water: Slightly Soluble: 0.1-1 mg/ml | | pka | 5.87±0.42(Predicted) |
| | 4H-Pyrido[1,2-a]pyrimidin-4-one, 7-(1-cyclopropyl-1H-pyrazol-4-yl)-2-[[2-fluoro-4-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]amino]-3-methyl- Usage And Synthesis |
| Uses | NVS-BPTF-1 is a selective inhibitor for bromodomain and PHD finger containing transcription factor (BPTF), with KD of 71 nM[1]. | | References | [1] Mélin L, et al., Synthesis of NVS-BPTF-1 and evaluation of its biological activity. Bioorg Med Chem Lett. 2021 Sep 1;47:128208. DOI:10.1016/j.bmcl.2021.128208 |
| | 4H-Pyrido[1,2-a]pyrimidin-4-one, 7-(1-cyclopropyl-1H-pyrazol-4-yl)-2-[[2-fluoro-4-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]amino]-3-methyl- Preparation Products And Raw materials |
|